Europe Medical Marijuana Market Forecast to 2028
Europe Medical Marijuana Market Forecast to 2028 – Regional Analysis – by Product Type (Dried Form and Extract Form), Application (Pain Management, Tourette’s, Alzheimer’s Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer, and Others), and Distribution Channel (Retail Pharmacy, E-Commerce, and Others)
$2,100 – $3,500
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Approvals of Medical Marijuana Fuels Europe Medical Marijuana Market Growth
Recent initiatives related to the legality of medical marijuana in Europe have been indicative of a broader trend toward acceptance and acknowledgment of the therapeutic potential of cannabis. Germany, for instance, stands as one of the leaders in its robust medical marijuana market, having legalized it in 2017. The country has expanded the list of eligible medical conditions for cannabis treatment, witnessing a surge in patient registrations and imports of medical marijuana. France embarked on a two-year pilot program in 2021 to assess the feasibility and efficacy of medical cannabis for specific ailments, marking a notable step forward. The UK legalized medical marijuana in 2018, permitting a specialist doctor to prescribe cannabis-based products for specific medical conditions. However, access issues have prompted a government review to improve patient accessibility.
Moreover, Italy boasts an established medical cannabis program that caters to patients with various conditions, with ongoing efforts to streamline regulations and broaden access. The Netherlands, renowned for its progressive drug policies, provides access to medical marijuana through pharmacies. Also, Luxembourg announced plans to become the first European nation to fully legalize recreational cannabis use, signaling evolving attitudes toward cannabis. Greece, on the other hand, legalized medical cannabis in 2017, encouraging investments in cultivation, processing, and distribution. These developments collectively reflect the shifting landscape of medical marijuana in Europe, with an increasing number of countries recognizing its therapeutic value for patients with specific medical needs.
Europe Medical Marijuana Market Overview
The Europe medical marijuana market is divided into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The Europe region holds a significant market share in the medical marijuana market. Europe occupies a significant position in the Europe medical marijuana market and is estimated to register a robust growth rate over the forecast period. The market growth in the region is attributed to the growing life science research and increasing investment in research and development.
Europe Medical Marijuana Market Revenue and Forecast to 2028 (US$ Million)
Europe Medical Marijuana Market Segmentation
The Europe medical marijuana market is segmented into product type, application, distribution channel, and country.
Based on product type, the Europe medical marijuana market is segmented into dried form and extract form. The extract form segment held a larger share of the Europe medical marijuana market in 2022.
Based on application, the Europe medical marijuana market is segmented into pain management, Tourette’s, Alzheimer’s disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held the largest share of the Europe medical marijuana market in 2022.
Based on distribution channel, the Europe medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held the largest share of the Europe medical marijuana market in 2022.
Based on country, the Europe medical marijuana market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe medical marijuana market in 2022.
Aphria, Inc.; Canopy Growth Corporation; GW Pharmaceuticals; Panaxia Pharmaceutical Industries Ltd.; and VIVO Cannabis Inc are some of the leading companies operating in the Europe medical marijuana market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to the research team’ research, the Europe medical marijuana market was valued at US$ 3,414.26 million in 2022 and is expected to reach US$ 9,703.38 million by 2028, registering a CAGR of 19.0% from 2022 to 2028. Increasing approvals of medical marijuana is the critical factor attributed to the Europe medical marijuana market expansion.
Pharmaceutical integration represents a fundamental side of the burgeoning European medical marijuana market. As more European countries recognize the therapeutic potential of cannabis-based medicines, pharmaceutical companies are increasingly exploring opportunities within the growing sector. The integration involves the development of standardized, pharmaceutical-grade cannabis products, which align with the stringent quality and safety standards of the pharmaceutical industry. Pharmaceutical integration benefits the medical marijuana market in several ways. Firstly, it encourages a sense of credibility and trust among healthcare professionals and patients. Pharmaceutical companies are providing them with a legacy of research, rigorous testing, and adherence to regulatory guidelines. This ensures product quality and consistency. Moreover, pharmaceutical integration leads to the creation of more precise and predictable medical cannabis formulations. Patients can benefit from medicines with known cannabis profiles, ensuring reliable and consistent therapeutic outcomes. Additionally, pharmaceutical companies can leverage their distribution networks and research capabilities to expand patient access to these medicines. Thus, the aforementioned factors are expected to offer lucrative opportunities to the players operating in the European medical marijuana market.
On the contrary, cultural and social stigma hampers the Europe medical marijuana market.
Based on product type, the Europe medical marijuana market is segmented into dried form and extract form. The extract form segment held 62.3% share of Europe medical marijuana market in 2022, amassing US$ 2,125.71 million. It is projected to garner US$ 6,066.77 million by 2028 to expand at 19.1% CAGR during 2022–2028.
Based on application, the Europe medical marijuana market is segmented into pain management, tourette’s, alzheimer’s disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others. The pain management segment held 25.3% share of Europe medical marijuana market in 2022, amassing US$ 865.17 million. It is projected to garner US$ 2,385.33 million by 2028 to expand at 18.4% CAGR during 2022–2028.
Based on distribution channel, the Europe medical marijuana market is segmented into retail pharmacy, e-commerce, and others. The retail pharmacy segment held 45.4% share of Europe medical marijuana market in 2022, amassing US$ 1,550.38 million. It is projected to garner US$ 4,373.01 million by 2028 to expand at 18.9% CAGR during 2022–2028.
Based on country, the Europe medical marijuana market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.6% share of Europe medical marijuana market in 2022. It was assessed at US$ 907.66 million in 2022 and is likely to hit US$ 2,606.68 million by 2028, exhibiting a CAGR of 19.2% during 2022–2028.
Key players operating in the Europe medical marijuana market are Aphria, Inc.; Canopy Growth Corporation; GW Pharmaceuticals; Panaxia Pharmaceutical Industries Ltd.; and VIVO Cannabis Inc, among others.
In November 2021, VIVO Cannabis Inc. launched its newest medical cannabis product formulation: high-dose cannabidiol (CBD) oil under its Beacon Medical brand. The entire family of Beacon Medical oil products are formulated using a non-GMO, food-grade medium-chain triglycerides (MCT) carrier oil which results in the final product being both scentless and flavorless in taste. VIVO simultaneously launched a Pediatric Compassionate Care Program to support caregivers and families requiring medical cannabis to treat a variety of pediatric conditions.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe medical marijuana market .
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe medical marijuana market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Europe Medical Marijuana Market – by Product
1.3.2 Europe Medical Marijuana Market – by Application
1.3.3 Europe Medical Marijuana Market – by Distribution Channel
1.3.4 Europe Medical Marijuana Market – by Country
2. Europe Medical Marijuana Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Medical Marijuana Market – Market Landscape
4.1 Overview
4.2 Europe– PEST Analysis
4.3 Expert Opinion
5. Europe Medical Marijuana Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Approvals of Medical Marijuana
5.2 Market Restraints
5.2.1 Cultural and Social Stigma
5.3 Market Opportunities
5.3.1 Pharmaceutical Integration in the Medical Marijuana Market
5.4 Future Trends
5.4.1 Regional Trade and Collaboration in the Medical Marijuana Market
5.5 Impact Analysis
6. Medical Marijuana Market –Europe Analysis
6.1 Europe Medical Marijuana Market Revenue Forecast and Analysis
7. Europe Medical Marijuana Market Revenue and Forecast To 2028– by Product
7.1 Overview
7.2 Europe Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
7.3 Dried Form
7.3.1 Overview
7.3.2 Dried Form: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Extract Form
7.4.1 Overview
7.4.2 Extract Form: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Medical Marijuana Market Analysis – by Application
8.1 Overview
8.2 Europe Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
8.3 Pain Management
8.3.1 Overview
8.3.2 Pain Management: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Tourette’s
8.4.1 Overview
8.4.2 Tourette’s: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Alzheimer’s Disease
8.5.1 Overview
8.5.2 Alzheimer’s Disease: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Migraines
8.6.1 Overview
8.6.2 Migraines: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Depression and Anxiety
8.7.1 Overview
8.7.2 Depression and Anxiety: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Multiple Sclerosis
8.8.1 Overview
8.8.2 Multiple Sclerosis: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
8.9.1 Overview
8.9.2 Cancer: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Medical Marijuana Market – by Distribution Channel
9.1 Overview
9.2 Europe Medical Marijuana Market , by Distribution Channel (2021 and 2028)
9.3 Retail Pharmacy
9.3.1 Overview
9.3.2 Retail Pharmacy: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9.4 E-Commerce
9.4.1 Overview
9.4.2 E-commerce: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Medical Marijuana Market Revenue and Forecast to 2028 – Country Analysis
10.1 Overview
10.1.1 Europe Medical Marijuana Market , by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Germany: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.2 Germany: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.4 Germany: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 UK: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 UK: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.2 UK: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 UK: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.4 UK: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 France: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 France: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.2 France: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 France: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 France: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Italy: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Italy: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.2 Italy: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.4 Italy: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Spain: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Spain: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.2 Spain: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.4 Spain: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Rest of Europe: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.2 Rest of Europe: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.4 Rest of Europe: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
11. Europe Medical Marijuana Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Europe Medical Marijuana Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 VIVO Cannabis Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Panaxia Pharmaceutical Industries Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Aphria, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Canopy Growth Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GW Pharmaceuticals
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About Research Team
13.2 Glossary of Terms for Europe Medical Marijuana Market
LIST OF TABLES
Table 1. Germany: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 4. UK: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
Table 5. UK: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 10. Italy: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of Europe: Europe Medical Marijuana Market , by Product– Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Europe Medical Marijuana Market , by Application – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Europe Medical Marijuana Market , by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 19. Organic Developments in the Europe Medical Marijuana Market
Table 20. Inorganic Developments in the Europe Medical Marijuana Market
Table 21. Glossary of Terms for Europe Medical Marijuana Market
LIST OF FIGURES
Figure 1. Europe Medical Marijuana Market Segmentation
Figure 2. Europe Medical Marijuana Market , By Country
Figure 3. Europe Medical Marijuana Market Overview
Figure 4. Extract Form Held Largest Share of Product Segment in Europe Medical Marijuana Market
Figure 5. The UK to Show Remarkable Growth During Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Medical Marijuana Market – Revenue Forecast and Analysis – 2020- 2028
Figure 8. Europe Medical Marijuana Market Revenue Share, by Product (2021 and 2028)
Figure 9. Dried Form: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Extract Form: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Medical Marijuana Market Revenue Share, by Application (2021 and 2028)
Figure 12. Pain Management: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Tourette’s: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Alzheimer’s Disease: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Migraines: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Depression and Anxiety: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Multiple Sclerosis: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Cancer: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Medical Marijuana Market , by Distribution Channel (2021 and 2028)
Figure 21. Retail Pharmacy: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. E-commerce: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Medical Marijuana Market , by Key Country – Revenue (2021) (US$ Million)
Figure 25. Europe Medical Marijuana Market , by Country, 2021 & 2028 (%)
Figure 26. Germany: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. UK: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. France: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Italy: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Spain: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Rest of Europe: Europe Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Growth Strategies in the Europe Medical Marijuana Market (%)
The List of Companies – Europe Medical Marijuana Market
o Aphria, Inc.
o Canopy Growth Corporation
o GW Pharmaceuticals
o Panaxia Pharmaceutical Industries Ltd.
o VIVO Cannabis Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.